The UPC – Three Years in Cross-Border Medtech Patent Strategy in the New European Landscape | McDermott Skip to main content

The UPC – Three Years in Cross-Border Medtech Patent Strategy in the New European Landscape

Overview


Frédéric Chevallier, Henrik Holzapfel, and Chuck Larsen will speak on the AdvaMed‑hosted webinar, “The UPC – Three Years In: Cross‑Border Medtech Patent Strategy in the New European Landscape.” The program will examine practical, cross‑border patent litigation strategies for navigating the Unified Patent Court (UPC) from a medtech‑specific perspective, drawing on recent UPC trends, case law, and real‑world experience from companies actively using the Court. The discussion will also address access considerations for Small and Medium-Sized Enterprises, the growing role of expert hearings, and strategic coordination of UPC proceedings with European national courts and US litigation.

Visit the AdvaMed website to register.

Dig Deeper

Boston, MA / Speaking Engagements / April 29-30, 2026

LSPN North America Spring 2026

New York, NY / Speaking Engagements / April 21-22, 2026

ACI’s 22nd Annual Paragraph IV Disputes

Chicago, IL / Speaking Engagements / March 10-11, 2026

World IP Review Summit 2026

Chicago, IL / Speaking Engagements / February 5, 2026

INTA Annual Case Law Review

Get In Touch